31 January 2025 in Journal of Global Health
Antimicrobial resistance (AMR) has become a global health problem [1]. It was associated with approximately 4.95 million deaths worldwide in 2019, of which 1.27 million were directly attributable [2]. As antibiotic consumption is an essential driver behind this phenomenon [3,4], promoting their rational use is a key strategy to control, which is one of the […]
8 September 2025 in BMJ Open Diabetes Research & Care
Introduction: To examine the association of the number of controlled risk factors with the excess risk of severe metabolic dysfunction-associated steatotic liver disease (MASLD) and major adverse liver outcomes (MALO) among patients with type 2 diabetes. Research design and methods: In this cohort study, a total of 307,688 participants from the UK Biobank were included. Participants with baseline type 2 diabetes were categorized according to the number of risk factors within the guideline-recommended ranges (diet, smoking, drinking, exercise, sedentary behavior, body mass index, glycated hemoglobin, blood pressure, and low-density lipoprotein cholesterol). Results: During a median (IQR) of 12.5 (11.8–13.2) years of follow-up, 519 (3.9%) participants with type 2 diabetes and 2718 (0.9%) participants without diabetes developed severe MASLD. Patients with type 2 diabetes had an increased risk of severe MASLD compared with participants without diabetes (HR 3.93, 95% CI 3.56 to 4.33), but the excess risk decreased stepwise with an increasing number of risk factors on target (HR (95% CI) for zero to two controlled risk factors: 5.44 (4.09 to 7.25); three controlled risk factors: 4.47 (3.59 to 5.57); four controlled risk factors: 4.16 (3.49 to 4.96); five controlled risk factors: 3.91 (3.28 to 4.66); six controlled risk factors: 3.50 (2.80 to 4.38); seven to nine controlled risk factors: 2.61 (1.92 to 3.56)). Similar patterns were observed in the analysis of MALO. Conclusions: Patients with type 2 diabetes who had more controlled risk factors showed progressively lower excess risk of severe MASLD and MALO. Comprehensive interventions targeting multiple risk factors may be associated with reduced liver lesions in patients with type 2 diabetes.
3 October 2025 in Journal of Global Health
There is widespread consensus in the scientific community that obesity ranks as one of the leading public health challenges of the 21st century [1]. Globally, 43% of adults were overweight and 16% were living with obesity [2]. It is reported that two-thirds of excess mortality in obese people is attributable to cardiovascular disease (CVD) [3], […]